Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zeller Entspannung for Cortisol Response in Acute Stress
NCT02189239Phase 4Completed
- Sponsor
- Max Zeller Söhne
- Start
- Jan 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of relaxane in acute stress disorder (ASD), sponsored by Max Zeller Söhne. Started Jan 2015; status: completed.
02
Drugs
relaxane
03
Conditions
acute stress disorder (ASD)
Beyond the preview
Go deeper on NCT02189239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02189239.